生物活性 | |||
---|---|---|---|
描述 | CCK antagonist 1 is a CCK antagonist with IC50s of 1.1 μM and 4 μM for CCK1 and CCK2, respectively, which is utilized in cancer and mental disease research[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.67mL 0.53mL 0.27mL |
13.35mL 2.67mL 1.34mL |
26.71mL 5.34mL 2.67mL |
参考文献 |
---|
[1]Eric Lattmann, et al. Novel ureido - and amido-pyrazolone derivatives. Patent WO2004106306A1. |